09/08/2024
Read about covid patented in 1965
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Logo of phenaturepg
Mol Gen Microbiol Virol. 2021; 36(1): 10–14. Published online 2021 Jun 3. doi: 10.3103/S0891416821010055
PMCID: PMC8173861PMID: 34103786
SARS-CoV-2 and Patent Activity
I. B. Nikitinacorresponding author and E. A. Smirnova
Author information Article notes Copyright and License information PMC Disclaimer
Go to:
Abstract
The article provides information on the patent activity of inventors in relation to applications for inventions related to coronaviruses, in particular, to SARS-CoV-2. The presence of a steady interest in this topic for the period 1996–2020 is illustrated. It is indicated what objects of patent law can be inventions related to vaccines.
Keywords: Keywords: patent law, coronavirus, SARS-CoV-2, invention
As is known, in March 2020, the WHO declared a pandemic for SARS-CoV-2. But even before this event, since the very beginning of 2020, the whole world began to follow the development of events in China. Thus, the beginning of 2020 was marked by the fact that not only specialists learned about the existence of coronaviruses, but also ordinary people. Virologists have known about coronaviruses since 1937, when the first coronavirus was discovered. It was the avian infectious bronchitis virus (IBV). On the other hand, human coronaviruses have been known since the 1960s. However, these viruses did not receive much attention [1].
The first human coronavirus was isolated by D. Tyrrell and M. Bynoe in 1965 from a patient with acute rhinitis. Until 2002, coronaviruses were considered to be the causative agent of mild rhinitis in humans [2].